Want to see CVS full AI Analyst Report?
CVS Stock Chart & Stats
$107.74
-$1.09(-1.01%)
At close: 4:00 PM EDT
$107.74
-$1.09(-1.01%)
Day’s Range― - ―
52-Week Range$62.52 - $110.68
Previous CloseN/A
Volume1.70M
Average Volume (3M)7.39M
Market Cap
$133.25B
Enterprise Value$195.69K
Total Cash (Recent Filing)$13.96B
Total Debt (Recent Filing)$76.31B
Price to Earnings (P/E)45.2
Beta0.51
Next Earnings
Nov 04, 2026EPS Estimate
1.66Next Dividend Ex-DateN/A
Dividend Yield2.55%
Share Statistics
EPS (TTM)3.83
Shares Outstanding1,275,927,200
10 Day Avg. Volume8,144,975
30 Day Avg. Volume7,388,255
Financial Highlights & Ratios
PEG Ratio-0.92
Price to Book (P/B)1.34
Price to Sales (P/S)0.25
P/FCF Ratio12.88
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda<0.01
Forecast
1Y Price Target
$112.47Price Target Upside4.39% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering18
EPS Forecast (FY)7.45
Revenue Forecast (FY)$408.82B
Bulls Say, Bears Say
Bulls Say
Specialty Pharmacy LeadershipConsistently high specialty adherence (>90%) is a durable competitive advantage: it strengthens relationships with payers and manufacturers, supports higher-margin specialty dispensing and clinical services, and increases patient stickiness and long-term revenue visibility in specialty care.
Improving Cash Generation And DeleveragingSubstantial free cash flow and declining debt represent durable financial strength: higher FCF and lower leverage improve flexibility to fund tech investments, sustain dividends, and absorb reimbursement volatility, while reducing interest burden and supporting multi-year strategic initiatives.
Large Tech & AI Investment Unlocking EfficienciesA multi-decade technology commitment and early >$1B OpEx savings indicate structural productivity gains: AI-enabled claims and automation improve processing speed and margins, strengthen PBM/retail differentiation, and create sustainable operating leverage across the enterprise.
Bears Say
Compressed Profitability & Low ROEVery low margins and depressed return on equity reflect weaker earnings quality and less capacity to generate returns from the asset base. This structural profitability compression limits reinvestment capacity, reduces resilience to pricing/regulatory shocks, and constrains long-term shareholder returns.
340B Program HeadwindsOngoing 340B disruptions and manufacturer restrictions are a structural revenue and margin risk for related pharmacy services. Prolonged uncertainty can reduce specialty and contract pharmacy economics, hinder Caremark spreads, and impair medium‑term earnings visibility.
Anticipated Caremark Membership DeclinesExpected PBM membership declines reflect durable client contract repricing and shifts to lowest net cost models. Loss of scale reduces negotiating leverage, pressures purchasing economics and spreads, and can materially dampen Health Services revenue and margin over multiple quarters.
CVS Health News
CVS FAQ
What was CVS Health Corp’s price range in the past 12 months?
CVS Health Corp lowest stock price was $62.52 and its highest was $110.68 in the past 12 months.
What is CVS Health Corp’s market cap?
CVS Health Corp’s market cap is $133.25B.
When is CVS Health Corp’s upcoming earnings report date?
CVS Health Corp’s upcoming earnings report date is Nov 04, 2026 which is in 90 days.
How were CVS Health Corp’s earnings last quarter?
CVS Health Corp released its earnings results on Aug 05, 2026. The company reported $2.58 earnings per share for the quarter, beating the consensus estimate of $1.854 by $0.726.
Is CVS Health Corp overvalued?
According to Wall Street analysts CVS Health Corp’s price is currently Undervalued.
Does CVS Health Corp pay dividends?
CVS Health Corp pays a Quarterly dividend of $0.665 which represents an annual dividend yield of 2.55%. See more information on CVS Health Corp dividends here
What is CVS Health Corp’s EPS estimate?
CVS Health Corp’s EPS estimate is 1.66.
How many shares outstanding does CVS Health Corp have?
CVS Health Corp has 1,275,927,200 shares outstanding.
What happened to CVS Health Corp’s price movement after its last earnings report?
CVS Health Corp reported an EPS of $2.58 in its last earnings report, beating expectations of $1.854. Following the earnings report the stock price went down -5.076%.
Which hedge fund is a major shareholder of CVS Health Corp?
Currently, no hedge funds are holding shares in CVS
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
CVS Health Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$112.47 (4.39% Upside)
$112.47 (4.39% Upside)
Blogger Sentiment
Bullish
CVS Sentiment 85%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Decreased
By 18.9M Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $323.7M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Positive
Last 7 Days ▼ 0.2%
Last 30 Days ▲ 2.9%
Last 30 Days ▲ 2.9%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
81.99%
12-Months-Change
Fundamentals
Return on Equity
2.55%
Trailing 12-Months
Asset Growth
-1.02%
Trailing 12-Months
Company Description
CVS Health Corp
CVS Health Corp. is a health solutions company, which engages in the provision of healthcare services. It operates through the following segments: Health Care Benefits, Health Services, Pharmacy and Consumer Wellness, and Corporate and Other. The Health Care Benefits segment operates as a health care benefits provider. The Health Services segment offers a full range of PBM solutions, delivers health care services in its medical clinics, virtually, and in the home. The Pharmacy & Consumer Wellness segment dispenses prescriptions in its retail pharmacies and through its infusion operations. The Corporate and Other Segment is involved in management and administrative expenses. The company was founded by Stanley P. Goldstein and Ralph Hoagland in 1963 and is headquartered in Woonsocket, RI.
CVS Company Deck
CVS Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call conveyed strong operational and financial momentum across segments with material upside: double-digit growth in operating income, raised EPS guidance, improved cash flow outlook, specialty leadership, and early tangible AI-driven efficiencies. Offsetting these positives are notable industry-specific headwinds—most prominently near-term 340B pressures, anticipated Caremark membership declines in 2027, ongoing reimbursement and regulatory pressures, and some timing-related pull-forwards. Management emphasized disciplined execution, balance sheet improvement and a multi-year growth outlook (mid-teens EPS CAGR through 2028), while acknowledging and preparing for specific near-term headwinds.View all CVS earnings summariesCVS Revenue Breakdown
46.57% Health Services
35.05% Health Care Benefits
33.40% Pharmacy & Consumer Wellness
0.12% Corporate/ Other
CVS Stock 12 Month Forecast
Average Price Target
$112.47
▲(4.39% Upside)
Technical Analysis
Ownership Overview
0.41% Insiders
32.79% Mutual Funds
2.98% Other Institutional Investors
42.12% Public Companies and Individual Investors